These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 25545020)
1. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term. Macías J; Mancebo M; Márquez M; Merino D; Téllez F; Rivero A; von Wichmann MA; López-Cortés LF; Merchante N; Santos J; Raffo M; Pérez-Pérez M; Camacho Á; Iribarren JA; Pineda JA Hepatology; 2015 May; 61(5):1503-11. PubMed ID: 25545020 [TBL] [Abstract][Full Text] [Related]
2. Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy. Macías J; Márquez M; Téllez F; Merino D; Jiménez-Aguilar P; López-Cortés LF; Ortega E; von Wichmann MA; Rivero A; Mancebo M; Santos J; Pérez-Pérez M; Suárez-Lozano I; Romero-Palacios A; Torres-Cornejo A; Pineda JA Clin Infect Dis; 2013 Nov; 57(10):1401-8. PubMed ID: 23946224 [TBL] [Abstract][Full Text] [Related]
3. Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients. Macías J; Camacho A; Von Wichmann MA; López-Cortés LF; Ortega E; Tural C; Ríos MJ; Merino D; Téllez F; Márquez M; Mancebo M; Pineda JA AIDS; 2013 Oct; 27(16):2541-9. PubMed ID: 23736148 [TBL] [Abstract][Full Text] [Related]
4. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients. Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826 [TBL] [Abstract][Full Text] [Related]
5. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline. Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909 [TBL] [Abstract][Full Text] [Related]
6. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis. Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J; Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746 [TBL] [Abstract][Full Text] [Related]
7. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography. Pérez-Latorre L; Sánchez-Conde M; Rincón D; Miralles P; Aldámiz-Echevarría T; Carrero A; Tejerina F; Díez C; Bellón JM; Bañares R; Berenguer J Clin Infect Dis; 2014 Mar; 58(5):713-8. PubMed ID: 24265358 [TBL] [Abstract][Full Text] [Related]
8. Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients. Verlinden W; Bourgeois S; Gigase P; Thienpont C; Vonghia L; Vanwolleghem T; Michielsen P; Francque S J Ultrasound Med; 2016 Jun; 35(6):1299-308. PubMed ID: 27151906 [TBL] [Abstract][Full Text] [Related]
9. Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies. Labarga P; Fernández-Montero JV; López M; Barreiro P; de Mendoza C; Sierra-Enguita R; Treviño A; Soriano V Antivir Ther; 2014; 19(8):799-803. PubMed ID: 24964405 [TBL] [Abstract][Full Text] [Related]
10. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Masuzaki R; Tateishi R; Yoshida H; Goto E; Sato T; Ohki T; Imamura J; Goto T; Kanai F; Kato N; Ikeda H; Shiina S; Kawabe T; Omata M Hepatology; 2009 Jun; 49(6):1954-61. PubMed ID: 19434742 [TBL] [Abstract][Full Text] [Related]
11. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3. Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients. Pineda JA; González J; Ortega E; Tural C; Macías J; Griffa L; Burgos A; J Viral Hepat; 2010 Oct; 17(10):714-9. PubMed ID: 20002560 [TBL] [Abstract][Full Text] [Related]
13. Course of liver fibrosis in HIV-hepatitis C virus-coinfected patients depending on the response to hepatitis C therapy. Cartón JA; Collazos J; de la Fuente B; Asensi V AIDS Res Hum Retroviruses; 2013 Feb; 29(2):215-22. PubMed ID: 22734850 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients. Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686 [TBL] [Abstract][Full Text] [Related]
15. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients. Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J; Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus. Berenguer J; Zamora FX; Aldámiz-Echevarría T; Von Wichmann MA; Crespo M; López-Aldeguer J; Carrero A; Montes M; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Barros C; Ortega E; Pulido F; Rubio R; Mallolas J; Tural C; Jusdado JJ; Pérez G; Díez C; Álvarez-Pellicer J; Esteban H; Bellón JM; González-García J; Clin Infect Dis; 2015 Mar; 60(6):950-8. PubMed ID: 25422386 [TBL] [Abstract][Full Text] [Related]
17. Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy. Labarga P; Fernandez-Montero JV; Barreiro P; Pinilla J; Vispo E; de Mendoza C; Plaza Z; Soriano V J Viral Hepat; 2014 Jul; 21(7):475-9. PubMed ID: 24750394 [TBL] [Abstract][Full Text] [Related]
18. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis. Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666 [TBL] [Abstract][Full Text] [Related]
19. Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection. Casado JL; Quereda C; Moreno A; Pérez-Elías MJ; Martí-Belda P; Moreno S J Viral Hepat; 2013 Dec; 20(12):829-37. PubMed ID: 24304452 [TBL] [Abstract][Full Text] [Related]
20. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis. García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ; AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]